NYU Langone Hospital - Long Island — Mineola, New York

Public research footprint of NYU Langone Hospital - Long Island, compiled from the ClinicalTrials.gov public registry.

218

Registered studies

157

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Anatomic Stage III Breast Cancer AJCC v8 · Metastatic Bladder Large Cell Neuroendocrine Carcinoma · Locally Advanced Malignant Solid Neoplasm · Resectable Pancreatic Acinar Cell Carcinoma

Recently updated registry entries

NCT07365319 — A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy… (Recruiting)
NCT06203600 — Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal… (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at NYU Langone Hospital - Long Island?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.